anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

171,361-171,420 of 319,975

filter-aware
38
BenevolentAI | SPAC Presentation Deck | 42 slidesBenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank 1 hit
39
The slide uses a competitive matrix to justify the company's valuation relative to peers.BenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank 1 hit
40
BenevolentAI | SPAC Presentation Deck | 42 slidesBenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank 1 hit
41
BenevolentAI | SPAC Presentation Deck | 42 slidesBenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank 1 hit
42
BenevolentAI | SPAC Presentation Deck | 42 slidesBenevolentAI | SPAC Presentation Deck | 42 slides · BenevolentAI
Pitch deck Investment bank 1 hit
01
Slide 1
Includes stock tickers (ASX: BNO, OTCQB: BNOEF) and date (December 2021).Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
02
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
03
Includes specific financial details like gross proceeds, use of proceeds, and bookrunners.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
04
The slide uses a vertical timeline-like structure to present key company highlights.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
05
The slide uses a grid layout to present leadership profiles and a list for the board of directors, supplemented by a logo grid representing past/current experience.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Beat · Team1 hit
06
The slide uses a Gantt-style layout to show clinical trial progress for BNC210 and collaborative programs.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
07
The slide uses a biological process diagram to illustrate how allosteric modulation works and a conceptual graph to show how the drug candidates normalize hyper- and hypo-cholinergic states.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
08
The slide uses a biological process diagram to contrast normal brain function with anxiety/PTSD states and the corrective effect of the drug.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
09
Slide 9 of the deck.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
10
Uses a funnel-like visual to represent market segmentation/prevalence.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Beat · Market Size1 hit
11
The study uses a CCK-4-induced panic attack model to measure efficacy.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
12
Includes fMRI and behavioral task (JORT) data.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
13
The slide uses a hub-and-spoke diagram to highlight BNC210's value proposition and a comparison table to frame the competitive landscape.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
14
Includes a pharmacokinetic chart showing concentration vs time for different doses.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Loop · Why Now1 hit
15
Includes clinical trial design flow chart and regulatory milestones.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
16
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
17
Uses a funnel-like visual to represent the narrowing of the patient population from total prevalence to those inadequately treated.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide uses a combination of a line chart for animal model data and a bar chart for human translational data to support the therapeutic thesis.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
19
The slide uses a circular diagram to show BNC210's core strengths and a comparison table to contrast it with current SSRI/SNRI treatments.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a process flow diagram to show the evolution of the drug program from initial trial results to the ongoing ATTUNE study.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
21
Includes a pharmacometric exposure-response curve and a pharmacokinetic time-concentration profile.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
22
The slide uses a timeline-based visual to explain the clinical trial structure.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
23
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
24
Includes three bar charts showing BNC375 efficacy in animal models.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
25
Uses a newspaper graphic to frame the MOU announcement as a significant news event.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
26
The slide features a stylized illustration of neurons, reinforcing the CNS theme.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
27
The chart shows reversal of PCP-induced cognitive deficits in mice, with percentages indicating the degree of reversal compared to vehicle/PCP controls.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
28
Uses a process flow for the genetic rationale and a box-based structure for the R&D status.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
29
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
30
Figures as of September 30, 2021.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
31
The slide uses a vertical timeline-like structure to list key strategic pillars.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
32
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
33
The table provides a comprehensive overview of clinical development progress across multiple phases and indications.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
34
The slide uses a structured table-like layout to present clinical trial parameters.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
35
The slide uses a mix of bullet points and a callout box for the conclusion/explanation of the primary endpoint failure.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
36
The slide uses a combination of a line chart for data and a process flow diagram to explain the mechanism of action.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
37
Bionomics | IPO Presentation Deck | 38 slidesBionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
38
Details the financial milestones (A$118M) and strategic partnership for CAR-T therapy development.Bionomics | IPO Presentation Deck | 38 slides · Bionomics
Pitch deck Investment bank 1 hit
01
Slide 1
Includes corporate branding, presenter name, title, and date.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Setup1 hit
02
Includes reference to SEC filings and GAAP/non-GAAP reporting policy.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Setup1 hit
03
The slide uses a simple additive diagram to explain the components of EPS growth.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses a scatter plot to show correlation between growth and valuation, and a bar chart to show relative growth rates.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The chart uses a Marimekko-style layout to visualize revenue contribution vs growth rates.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
06
The slide uses a concentric circle diagram to represent the strategic focus areas.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
07
The 'Sustainable' category represents organic asset growth rather than fee growth.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
08
The chart illustrates the 'moat' as the delta between BLK growth and Industry growth.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
09
The slide uses a before-after comparison to show growth in scale (AUM, employees) relative to efficiency (operating margin).BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
10
The slide uses a stacked bar chart to show the composition of compensation expenses over time, alongside qualitative drivers.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
11
The chart shows a shift in G&A composition, with a reduction in 'Other core G&A' and an increase in 'Tech, data and other portfolio services'.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide uses a vertical process flow to illustrate capital allocation priorities.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
13
The slide uses a box-within-a-box layout to show how core business drivers (Organic growth, Operating leverage, Capital management) lead to EPS growth, framed by organizational strengths.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · ResolutionLoop · Cost Of Inaction1 hit
14
This is a standard legal/methodological appendix slide for a corporate presentation.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Resolution1 hit
15
Contains specific methodology and source disclosures for slides 8, 10, 11, and 12.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Resolution1 hit
16
BlackRock | Investor Conference Presentation Deck | 20 slidesBlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Resolution1 hit
17
The slide provides a bridge between GAAP and non-GAAP financial metrics.BlackRock | Investor Conference Presentation Deck | 20 slides · BlackRock
Conference presentation Investor relations Beat · Resolution1 hit